Air leak test in the Paediatric Intensive Care Unit (ALTIPICU): rationale and protocol for a prospective multicentre observational study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
30 Apr 2024
Historique:
medline: 1 5 2024
pubmed: 1 5 2024
entrez: 30 4 2024
Statut: epublish

Résumé

In children, respiratory distress due to upper airway obstruction (UAO) is a common complication of extubation. The quantitative cuff-leak test (qtCLT) is a simple, rapid and non-invasive test that has not been extensively studied in children. The objective of the ongoing study whose protocol is reported here is to investigate how well the qtCLT predicts UAO-related postextubation respiratory distress in paediatric intensive care unit (PICU) patients. Air Leak Test in the Paediatric Intensive Care Unit is a multicentre, prospective, observational study that will recruit 900 patients who are aged 2 days post-term to 17 years and ventilated through a cuffed endotracheal tube for at least 24 hours in any of 19 French PICUs. Within an hour of planned extubation, the qtCLT will be performed as a sequence of six measurements of the tidal volume with the cuff inflated then deflated. The primary outcome is the occurrence within 48 hours after extubation of severe UAO defined as combining a requirement for intravenous corticosteroid therapy and/or ventilator support by high-flow nasal cannula and/or by non-invasive ventilation or repeat invasive mechanical ventilation with a Westley score ≥4 with at least one point for stridor at each initiation. The results of the study are expected to identify risk factors for UAO-related postextubation respiratory distress and extubation failure, thereby identifying patient subgroups most likely to require preventive interventions. It will also determine whether qtCLT appears to be a reliable method to predict an increased risk for postextubation adverse events as severe UAO. The study was approved by the Robert Debré University Hospital institutional review board (IRB) on September 2021 (approval #2021578). The report of Robert Debré University Hospital IRB is valid for all sites, given the nature of the study with respect to the French law. The results will be submitted for publication in a peer-reviewed journal. NCT05328206.

Identifiants

pubmed: 38688666
pii: bmjopen-2023-081314
doi: 10.1136/bmjopen-2023-081314
doi:

Banques de données

ClinicalTrials.gov
['NCT05328206']

Types de publication

Journal Article Research Support, Non-U.S. Gov't Multicenter Study Observational Study Clinical Trial Protocol

Langues

eng

Sous-ensembles de citation

IM

Pagination

e081314

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Boris Lacarra (B)

Médecine Intensive-Réanimation Pédiatrique, Robert-Debré Mother-Child University Hospital, Paris, Île-de-France, France boris.lacarra@gmail.com.

Aurélie Hayotte (A)

Médecine Intensive-Réanimation Pédiatrique, Robert-Debré Mother-Child University Hospital, Paris, Île-de-France, France.
Université Paris Cité, Paris, France.

Jérôme Naudin (J)

Médecine Intensive-Réanimation Pédiatrique, Robert-Debré Mother-Child University Hospital, Paris, Île-de-France, France.

Arielle Maroni (A)

Médecine Intensive-Réanimation Pédiatrique, Robert-Debré Mother-Child University Hospital, Paris, Île-de-France, France.

Guillaume Geslain (G)

Médecine Intensive-Réanimation Pédiatrique, Robert-Debré Mother-Child University Hospital, Paris, Île-de-France, France.

Géraldine Poncelet (G)

Médecine Intensive-Réanimation Pédiatrique, Robert-Debré Mother-Child University Hospital, Paris, Île-de-France, France.

Michael Levy (M)

Médecine Intensive-Réanimation Pédiatrique, Robert-Debré Mother-Child University Hospital, Paris, Île-de-France, France.
Université Paris Cité, Paris, France.

Matthieu Resche-Rigon (M)

Université Paris Cité, Paris, France.
ECSTRRA Team-CRESS-UMR 1153, INSERM U1153, Paris, Île-de-France, France.

Stéphane Dauger (S)

Médecine Intensive-Réanimation Pédiatrique, Robert-Debré Mother-Child University Hospital, Paris, Île-de-France, France.
Université Paris Cité, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH